CARB-X Presentation – 2018 Funding Cycle
CARB-X is the world’s largest-public-private partnership devoted to early development antibacterial R&D. CARB-X has announced the opening of its 2018 funding cycle to support the early development of antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria.
Please join NCBiotech and RTI International as we host the Executive Director of CARB-X, Kevin Outterson, for an informational session about CARB-X and their newest funding cycle. Kevin will provide an overview of the CARB-X initiative and leave plenty of time to get all questions answered.
No registration is needed to attend.
For further information, please refer to the CARB-X press release and website.
Agenda
10:00am - Presentation by Kevin Outterson, Executive Director, CARB-X
10:30am - Q&A Session
11:00am - Networking
11:30am - Adjourn
More Information
For further information, please refer to the CARB-X press release and website and the CARB-X 2018 Funding Rounds presentation by Kevin Outterson, Executive Director, CARB-X during the CARB-X Funding Information Session Event held at the NC Biotech Center on March 9, 2018.
NCBiotech
15 T.W. Alexander Drive
Research Triangle Park, NC 27709